| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $18K | +157.1% | — |
| Cost of Revenue | $1K | +0.0% | — |
| R&D Expense | $52K | -30.7% | -36.6% |
| SG&A Expense | $261K | +6.1% | +97.7% |
| Operating Income | -$948K | +17.8% | +15.9% |
| Interest Expense | $262K | +0.8% | -14.1% |
| Pre-tax Income | -$1.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $12K | -98.1% | -99.6% |
| Accounts Receivable | $15K | -92.5% | — |
| Inventory | $485K | -0.2% | — |
| Current Assets | $917K | -38.1% | -71.1% |
| Total Assets | $18.2M | -4.5% | -61.0% |
| Current Liabilities | $23.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.0M | — | — |
| Investing Cash Flow | $2K | — | — |
| Financing Cash Flow | $4.5M | — | — |
| -134.8% |
| Net Income | -$1.5M | +89.8% | -134.6% |
| EPS (Basic) | -$0.12 | +89.8% | -132.4% |
| EPS (Diluted) | -$0.12 | +89.8% | -300.0% |
| +2.7% |
| +1990.8% |
| Total Liabilities | $27.1M | +2.3% | +119.2% |
| Stockholders' Equity | -$11.8M | -14.2% | -137.7% |